Effect of AQW051 in Patients With Memory Impairment

Clinical trial NCT00582855 · TERMINATED

Trial details

NCT number: NCT00582855
Sponsor: Novartis Pharmaceuticals
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Mild Alzheimer's Disease Amnestic Mild Cognitive Impairment

Start date: 2007-12-01
Primary completion: 2009-02-01
Enrollment: 54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.